Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac N.V (CVAC) Return on Sales: 2020-2025

Historic Return on Sales for CureVac N.V (CVAC) over the last 2 years, with Jun 2025 value amounting to 0.38%.

  • CureVac N.V's Return on Sales rose 454.00% to 0.38% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.38%, marking a year-over-year increase of 454.00%. This contributed to the annual value of 0.30% for FY2024, which is 514.00% up from last year.
  • Per CureVac N.V's latest filing, its Return on Sales stood at 0.38% for Q2 2025, which was up 6.02% from 0.36% recorded in Q1 2025.
  • Over the past 5 years, CureVac N.V's Return on Sales peaked at 277.34% during Q1 2022, and registered a low of -8.03% during Q2 2023.
  • Over the past 3 years, CureVac N.V's median Return on Sales value was -4.39% (recorded in 2024), while the average stood at -3.30%.
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 28,537bps in 2022, then tumbled by 28,311bps in 2023.
  • Over the past 5 years, CureVac N.V's Return on Sales (Quarterly) stood at 170.11% in 2021, then soared by 6,301bps to 233.12% in 2022, then crashed by 23,796bps to -4.84% in 2023, then skyrocketed by 515bps to 0.31% in 2024, then spiked by 454bps to 0.38% in 2025.
  • Its Return on Sales stands at 0.38% for Q2 2025, versus 0.36% for Q1 2025 and 0.31% for Q4 2024.